JP2024069230A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024069230A5 JP2024069230A5 JP2024022711A JP2024022711A JP2024069230A5 JP 2024069230 A5 JP2024069230 A5 JP 2024069230A5 JP 2024022711 A JP2024022711 A JP 2024022711A JP 2024022711 A JP2024022711 A JP 2024022711A JP 2024069230 A5 JP2024069230 A5 JP 2024069230A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- dose
- human subject
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511832P | 2017-05-26 | 2017-05-26 | |
| US62/511,832 | 2017-05-26 | ||
| JP2019565281A JP7497159B2 (ja) | 2017-05-26 | 2018-05-26 | 慢性回腸嚢炎の治療のための方法 |
| PCT/IB2018/053760 WO2018215995A1 (en) | 2017-05-26 | 2018-05-26 | Methods for the treatment of chronic pouchitis |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565281A Division JP7497159B2 (ja) | 2017-05-26 | 2018-05-26 | 慢性回腸嚢炎の治療のための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024069230A JP2024069230A (ja) | 2024-05-21 |
| JP2024069230A5 true JP2024069230A5 (https=) | 2024-08-29 |
Family
ID=64395342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565281A Active JP7497159B2 (ja) | 2017-05-26 | 2018-05-26 | 慢性回腸嚢炎の治療のための方法 |
| JP2024022711A Pending JP2024069230A (ja) | 2017-05-26 | 2024-02-19 | 慢性回腸嚢炎の治療のための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565281A Active JP7497159B2 (ja) | 2017-05-26 | 2018-05-26 | 慢性回腸嚢炎の治療のための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200087401A1 (https=) |
| EP (1) | EP3630184A4 (https=) |
| JP (2) | JP7497159B2 (https=) |
| KR (1) | KR20200011457A (https=) |
| AU (1) | AU2018274749B2 (https=) |
| BR (1) | BR112019024875A2 (https=) |
| CA (1) | CA3065000A1 (https=) |
| IL (1) | IL270819A (https=) |
| MX (1) | MX2019014090A (https=) |
| WO (1) | WO2018215995A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016086147A1 (en) | 2014-11-26 | 2016-06-02 | Millennium Pharmaceuticals, Inc. | Vedolizumab for the treatment of fistulizing crohn's disease |
| WO2023163883A1 (en) * | 2022-02-22 | 2023-08-31 | First Wave BioPharma, Inc. | Compositions and methods for treating pouchitis |
| WO2024249568A1 (en) | 2023-05-30 | 2024-12-05 | Paragon Therapeutics, Inc. | Alpha4beta7 integrin antibody compositions and methods of use |
| CN121889424A (zh) | 2023-08-14 | 2026-04-17 | 派拉冈医疗公司 | α4β7整联蛋白结合蛋白及使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6551593B1 (en) * | 1995-02-10 | 2003-04-22 | Millennium Pharmaceuticals, Inc. | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| JP6904905B2 (ja) * | 2014-12-24 | 2021-07-21 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 抗α４β７インテグリン抗体による治療の結果の予測 |
-
2018
- 2018-05-26 AU AU2018274749A patent/AU2018274749B2/en active Active
- 2018-05-26 EP EP18806578.3A patent/EP3630184A4/en active Pending
- 2018-05-26 WO PCT/IB2018/053760 patent/WO2018215995A1/en not_active Ceased
- 2018-05-26 CA CA3065000A patent/CA3065000A1/en active Pending
- 2018-05-26 US US16/617,254 patent/US20200087401A1/en not_active Abandoned
- 2018-05-26 MX MX2019014090A patent/MX2019014090A/es unknown
- 2018-05-26 BR BR112019024875-7A patent/BR112019024875A2/pt unknown
- 2018-05-26 KR KR1020197037702A patent/KR20200011457A/ko not_active Ceased
- 2018-05-26 JP JP2019565281A patent/JP7497159B2/ja active Active
-
2019
- 2019-11-21 IL IL270819A patent/IL270819A/en unknown
-
2022
- 2022-03-18 US US17/655,541 patent/US20230043949A1/en active Pending
-
2024
- 2024-02-19 JP JP2024022711A patent/JP2024069230A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024069230A5 (https=) | ||
| JP7805788B2 (ja) | Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法 | |
| JP6278536B2 (ja) | 関節炎治療 | |
| CN115768466A (zh) | 用抗IL-23和TNFα抗体的联合疗法治疗炎性肠病的方法 | |
| JP2020507587A (ja) | 化膿性汗腺炎の処置 | |
| JP2022523530A (ja) | 化膿性汗腺炎の治療のための抗ＩＬ－α抗体 | |
| CN115702023A (zh) | 化脓性汗腺炎的治疗 | |
| AU2018274749A1 (en) | Methods for the treatment of chronic pouchitis | |
| US20240182581A1 (en) | Methods for the treatment of chronic pouchitis | |
| JPWO2021224499A5 (https=) | ||
| EP3371218A1 (en) | Treatment paradigm | |
| JP7798763B2 (ja) | Ｃ５関連疾患の治療または予防のための投与レジメン | |
| JPWO2022053653A5 (https=) | ||
| CN114423455A (zh) | 用于治疗系统性硬化症的药物组合物 | |
| JP2022520572A (ja) | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 | |
| JP2024517796A (ja) | 抗ｂａｆｆｒ抗体を使用するループス腎炎の治療 | |
| JP2020517648A5 (https=) | ||
| JPWO2020215019A5 (https=) | ||
| JP2024516019A (ja) | 抗ｂａｆｆｒ抗体を使用する全身性エリテマトーデスのための治療 | |
| WO2026060205A1 (en) | PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23p19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS | |
| IL323041A (en) | Methods for treating ulcerative colitis | |
| JPWO2023092062A5 (https=) | ||
| OSADA et al. | Current Treatment Options for Inflammatory Bowel Diseases and Future Perspectives | |
| JPWO2023144306A5 (https=) | ||
| TH2001001181A (th) | วิธีการสำหรับการบำบัดโรคที่เกี่ยวข้องกับ-tnf |